armamentarium of fundamental virology, with laboratory implementation for a limited array of
viruses only. Nevertheless, they represent the most reliable surrogate of potency for passive
immunotherapies, such as monoclonal or polyclonal antibody therapy. The recent interest
around therapy with convalescent plasma or monoclonal antibodies for the Covid‐19
pandemic has paralleled the revival of VNTs. We review here the available methods by …